Alere Inc. (NYSE:ALR) was down 3% during trading on Friday . The company traded as low as $38.80 and last traded at $39.45, with a volume of 1,099,180 shares. The stock had previously closed at $40.69.

A number of equities research analysts recently commented on ALR shares. Canaccord Genuity reaffirmed a “hold” rating on shares of Alere in a report on Saturday, April 30th. Leerink Swann reiterated a “buy” rating and set a $56.00 price target on shares of Alere in a research report on Tuesday, July 12th. Jefferies Group reiterated a “hold” rating on shares of Alere in a research report on Tuesday, July 12th. Finally, BTIG Research reiterated a “hold” rating on shares of Alere in a research report on Friday, July 15th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Alere currently has an average rating of “Hold” and a consensus target price of $52.13.

The firm’s market capitalization is $3.43 billion. The company’s 50 day moving average price is $39.98 and its 200-day moving average price is $44.73.

Alere (NYSE:ALR) last announced its earnings results on Wednesday, August 17th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by $0.74. The company earned $578 million during the quarter. During the same period in the previous year, the firm posted $0.53 earnings per share. The company’s revenue was down 5.7% compared to the same quarter last year. On average, equities analysts anticipate that Alere Inc. will post $2.38 EPS for the current fiscal year.

Alere Inc is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.